Nurse’s Attitudes and Perceptions Towards Medical Cannabis Legalization in Thailand
Abstract
Objective: To determine the attitudes and perceptions among nurses towards legalization of cannabis for medical use in Thailand.
Material and Methods: This anonymous, cross-sectional paper and online survey was conducted from May 2020 to November 2021. Data collection was done using the Cannabis as Medicine: Thai Nurse’s Attitudes and Perceptions Survey. Descriptive statistics were used to analyze the data.
Results: This study included 287 Thai registered nurses across Thailand. The top 3 positive attitudes and perceptions among the nurses were: 1) currently, most patients use or intend to use cannabis oil, 2) it’s not uncommon if nurses with advanced cancer decide to use cannabis oil, and 3) a patient’s values and beliefs in cannabis oil can them feel better. The top 3 negative attitudes and perceptions were: 1) cannabis reduces tumor growth in advanced cancer stages, 2) nurses administer medical cannabis as other medications; and (3) nurses like taking care of patients with the non-medicinal use of cannabis.
Conclusion: Thai registered nurses were more likely to have negative attitudes towards medical cannabis. The respondents required to increase their knowledge about medical cannabis. Understanding Thai nurses’ attitudes and perceptions towards medical cannabis use is necessary to see their insider views, the difficulties they face, and provide room for improvement to enhance the benefits and safety of medical cannabis use. Future research with larger sample sizes is recommended to strengthen the quality of evidence.
Keywords
Full Text:
PDFReferences
Ministry of Public Health. Narcotic Drugs Act No.7, B.E.2562 [homepage on Internet]. Nonthaburi: Food and Drug Administration, Narcotics Control Division; 2019 [cited 2021 Dec 6]. Available from: https://mnfda.fda.moph.go.th/narcotic/wp-content/uploads/2021/02/T_0001.pdf
Assanangkornchai S, Thaikla K, Talek M, Saingam D. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey. Peer J 2022;10:e12809.
Boehnke KF, Litinas E, Worthing B, Conine L, Kruger DJ. Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution. J Cannabis Res 2021;3:1-9.
Ministry of Public Health. Guidance on Cannabis for Medical Use [homepage on Internet]. 4th ed. 2021 [cited 2021 May 21]. Available from: https://mnfda.fda.moph.go.th/narcotic/wp-content/uploads/2021/04/Guidance-Updated-v-update-V.4260464.pdf
Gardiner KM, Singleton JA, Sheridan J, Kyle GJ, Nissen, LM. Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis–a systematic review. PLoS One 2019;14:e0216556.
Giannakopoulou M, Vouzavali F, Paikopoulou D, Paschali A, Mpouzika MD, Karanikola MNK. Attitudes, beliefs and knowledge towards medical cannabis of Greek undergraduate and postgraduate university nursing students. Complement Ther Med 2021;58:102703.
Ho BC, Barry AB, Koeppel JA, Macleod J, Boyd A, David A, O’Leary DS. Recreational Marijuana use, adolescent cognitive development, and schizophrenia susceptibility. Biol Psychiatry Glob Open Sci 2022;3:222-32.
Baratta F, Peira E, Maza C, Gallarate M, Brusa P. Cannabis-based oral emulsion for medical purposes to meet the needs of patients: formulation, quality and stability. Pharmaceutics 2022;14:513.
Fortin D, Marcellin F, Carrieri P, Mancini J, Barré T. Medical cannabis: toward a new policy and health model for an ancient medicine. Front Public Health 2022;10:904291.
Brady JP, Bruce D, Foster E, Shattell M. Self-efficacy in researching and obtaining medical cannabis by patients with chronic conditions. Health Educ Behav 2020;47:740-8.
Roberts J. Medical cannabis in adult mental health settings: reconstructing one of the most maligned medications in the United States. Clin Soc Work J 2020;48:412-20.
Rosenbæk F, Riisgaard H, Nielsen JB, Wehberg S, Waldorff FB, Pedersen LB, et al. GPs’ prescription patterns, experience, and attitudes towards medicinal cannabis-a nationwide survey at the early stage of the Danish test scheme. BMC Prim Care 2023;24:17.
Withanarachchie V, Rychert M, Wilkins C. The role of cannabis clinics in the health system: a qualitative study of physicians’ views in New Zealand. BMC Health Serv Res 2023;23:10.
Felnhofer A, Kothgassner OD, Stoll A, Klier C. Knowledge about and attitudes towards medical cannabis among Austrian university students. Complement Ther Med 2021;58:102700.
Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001;56:1059-68.
HaGani N, Sznitman S, Dor M, Bar-Sela G, Oren D, Margolis-Dorfman L, et al. Attitudes toward the use of medical cannabis and the perceived efficacy, side-effects and risks: a survey of patients, nurses and physicians. J Psychoactive Drugs 2022;54:393-402.
Melnikov S, Aboav A, Shalom E, Phriedman S, Khalaila K. The effect of attitudes, subjective norms and stigma on health-care providers’ intention to recommend medicinal cannabis to patients. Int J Nurs Pract 2021;27:e12836.
MacCallum CA, Eadie L, Barr AM, Boivin M, Lu S. Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Front Pharmacol 2021;12:633168.
Mekrungrongwong S, Kitreerawutiwong N, Keeratisiroj O, Jariya W. Self-perceived knowledge, attitudes, and training needs regarding medical cannabis among health care providers and health volunteers in district health systems, Phitsanulok Province. BMC Prim Care 2022;23:266.
Chappel JN, Veach TL, Krug RS. The substance abuse attitude survey: an instrument for measuring attitudes. J Stud Alcohol 1985;46:48-52.
Balneaves LG, Alraja A, Ziemianski D, McCuaig F, Ware M. A national needs assessment of Canadian nurse practitioners regarding cannabis for therapeutic purposes. Cannabis Cannabinoid Res 2018;3:66-73.
Jacobs NI, Montebello M, Monds LA, Lintzeris N. Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids. Australas Psychiatry 2019;27:80-5.
Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey. BMJ Open 2018;8:e022101.
Arnfinsen JL, Kisa A. Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis. Drugs 2021;28:165-171.
Carlini BH, Garrett SB, Carter GT. Medicinal cannabis: a survey among health care providers in Washington State. Am J Hosp Palliat Care. 2017;34:85-91.
Chan GCK, Hall W, Freeman TP, Ferris J, Kelly AB, Winstock A. User characteristics and effect profile of Butane Hash oil: an extremely high-potency cannabis concentrate. Drug Alcohol Depend. 2017;178:32-38.
Kanato M, Leyatikul PM, Wonguppa PL. Medical cannabis law in Thailand. ONCB J 2020;36.
Kaplan L, Klein T, Wilson M, Graves J. Knowledge, practices, and attitudes of Washington State health care professionals regarding medical cannabis. Cannabis Cannabinoid Res 2020;5:172-82.
Makki I, Zheng-Lin B, Kohli M. Medical marijuana knowledge and attitudes amongst internal medicine residents. BMC Prim Care 2022;23:38.
Nitti Y, Messmer PR. Critical factors that influence nurses’ knowledge, perceptions and attitudes of medical cannabis usage by patients [homepage on Internet]. Miami: Miami Dade College; 2021 [cited 2021 May 21]. Available from: https://sigma.nursingrepository.org/bitstream/handle/10755/18615/Slides.pdf?sequence=1
O’Rourke R, Lima ML, Jetten J. Healthcare professionals and medical cannabis: a scoping review informed by the theoretical domains framework. J Public Health 2022;30: 1901–1913.
Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam prac 2019;20:1-7.
Rice ASC, Belton J, Arendt Nielsen L. Presenting the outputs of the IASP presidential task force on cannabis and cannabinoid analgesia. Pain 2021;162(Suppl 1) S3-S4.
National Council of State Boards of Nursing. The NCSBN national nursing guidelines for medical marijuana. J Nurs Regul 2018;9,S3-S59.
Zolotov Y, Metri S, Calabria E, Kogan M. Medical cannabis education among healthcare trainees: a scoping review. Complement Ther Med 2021;58:102675.
Cheng KYC, Harnett JE, Davis SR, Eassey D, Law S, Smith L. Healthcare professionals’ perspectives on the use of medicinal cannabis to manage chronic pain: a systematic search and narrative review. Pain Pract 2022;22:718-32.
Clobes TA, Palmier LA, Gagnon M, Klaiman C, Arellano M. The impact of education on attitudes toward medical cannabis. PEC Innov 2022;1:100009.
Kurtzman ET, Greene J, Begley R, Drenkard KN. Nurse leaders’ attitudes toward and experiences with medical marijuana. J Nurs Regul 2022;13:10-24.
Earle KA. Medical cannabis: healthcare professionals’ attitudes, perceptions, and behaviors [homepage on Internet ]. Montana, Montana State University; 2020 [cited 2022 Feb 18]. Available from: https://scholarworks.montana.edu/xmlui/handle/1/15872
Minister of Health Canada. Cannabis Regulations [homepage on Internet]. Ontario: Digital Transformation Office, Government of Canada; 2020 [cited 2022 Feb 18]. Available from: from https://laws.justice.gc.ca/eng/regulations/SOR-2018-144/page-1.htm
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.